首页> 美国卫生研究院文献>Frontiers in Physiology >Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking
【2h】

Role of sinoatrial node architecture in maintaining a balanced source-sink relationship and synchronous cardiac pacemaking

机译:窦房结结构在维持平衡的源-库关系和同步心脏起搏中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Normal heart rhythm (sinus rhythm) depends on regular activity of the sinoatrial node (SAN), a heterogeneous collection of specialized myocytes in the right atrium. SAN cells, in general, possess a unique electrophysiological profile that promotes spontaneous electrical activity (automaticity). However, while automaticity is required for normal pacemaking, it is not necessarily sufficient. Less appreciated is the importance of the elaborate structure of the SAN complex for proper pacemaker function. Here, we review the important structural features of the SAN with a focus on how these elements help manage a precarious balance between electrical charge generated by the SAN (“source”) and the charge needed to excite the surrounding atrial tissue (“sink”). We also discuss how compromised “source-sink” balance due, for example to fibrosis, may promote SAN dysfunction, characterized by slow and/or asynchronous pacemaker activity and even failure, in the setting of cardiovascular disease (e.g., heart failure, atrial fibrillation). Finally, we discuss implications of the “source-sink” balance in the SAN complex for cell and gene therapies aimed at creating a biological pacemaker as replacement or bridge to conventional electronic pacemakers.
机译:正常的心律(窦律)取决于窦房结(SAN)的正常活动,窦房结(SAN)是右心房中专用肌细胞的异质集合。通常,SAN细胞具有独特的电生理特性,可促进自发的电活动(自动性)。但是,尽管正常的起搏器需要自动化,但这并不一定足够。对于复杂的起搏器功能,SAN复杂结构的重要性并不那么为人所知。在这里,我们回顾了SAN的重要结构特征,重点是这些元素如何帮助管理SAN产生的电荷(“源”)和激发周围心房组织(“汇”)所需的电荷之间的不稳定平衡。 。我们还讨论了诸如纤维化之类的“源-库”平衡受损如何在心血管疾病(例如心力衰竭,心房颤动)的环境中促进以功能缓慢和/或异步起搏器活动甚至失败为特征的SAN功能障碍。 )。最后,我们讨论了SAN复合体中“源-库”平衡对细胞和基因疗法的意义,这些疗法旨在创造一种生物起搏器作为传统电子起搏器的替代品或桥梁。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号